Indicator development will reflect priorities agreed with NHS England, the Department of Health and Social Care and the devolved administrations in Northern Ireland and Wales. These organisations in ...
Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer In many countries, cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback